Fenofibrate EP Impurity G
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

217636-48-1Fenofibrate EP Impurity G

● In Stock

Catalogue No.:VL59007
CAS No.:217636-48-1
Mol. Formula:C24H27ClO6
Mol. Weight:446.92

Additional information on CAS 217636-48-1

Parent drug

Fenofibrate

IUPAC Name

1-methylethyl2-[[2-[4-(4-chlorobenzoyl)phenoxy ]-2-methylpropanoyl]oxy]-2-methylpropanoate

Pharmacopoeial Synonyms

Fenofibrate Related Compound C

Other Synonyms

Propan-2-yl 2-[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl]oxy-2-methylpropanoate; Fenofibric Acid 1,1-Dimethyl-2-(1-methylethoxy)-2-oxoethyl Ester; 1-Isopropoxy-2-methyl-1-oxopropan-2-yl 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoate

Smile

CC(C)(OC(C(C)(OC1=CC=C(C(C2=CC=C(Cl)C=C2)=O)C=C1)C)=O)C(OC(C)C)=O

InChI

InChI=1S/C24H27ClO6/c1-15(2)29-21(27)23(3,4)31-22(28)24(5,6)30-19-13-9-17(10-14-19)20(26)16-7-11-18(25)12-8-16/h7-15H,1-6H3

Description

Fenofibrate EP Impurity G also referred to in pharmacopoeias as Fenofibrate Related Compound C, is a meticulously characterized reference standard. It adheres to stringent regulatory guidelines, including those established by USP, EMA, JP, and BP. This product plays a vital role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial manufacturing of Fenofibrate. Furthermore, it is accompanied by a comprehensive Structure Elucidation Report (SER), ensuring its accuracy and reliability across various analytical applications. Fenofibrate EP Impurity G (CAS No. 217636-48-1) or 1-methylethyl2-[[2-[4-(4-chlorobenzoyl)phenoxy ]-2-methylpropanoyl]oxy]-2-methylpropanoate is an impurity of Fenofibrate. Fenofibrate belongs to a group of drugs known as « fibrates. » Fenofibrate treats high cholesterol and triglyceride levels in the blood.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url